Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|July 29, 2023
Deciphering the Action of Neuraminidase in Glioblastoma ModelsNathalie Baeza-Kallee, Raphaël Bergès, Victoria Hein, et al.
Oncology Letters|September 12, 2012
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancersStéphane Raynaud, Nadine Carbuccia, Carole Colin, et al.
Plos One|April 13, 2011
Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptorAlexandra Canonici, Carole Siret, Emilie Pellegrino, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|September 5, 2006
Thalamic gliomas in children: an extensive clinical, neuroradiological and pathological study of 14 casesCarla Fernandez, André Maues de Paula, Carole Colin, et al.
Acta Neuropathologica Communications|September 9, 2018
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcomeRomain Appay, Emeline Tabouret, Mehdi Touat, et al.
Brain Pathology (Zurich, Switzerland)|February 28, 2013
Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expressionCéline Chappé, Laetitia Padovani, Didier Scavarda, et al.
Oncotarget|December 6, 2015
Molecular heterogeneity of glioblastomas: does location matter?Emilie Denicolaï, Emeline Tabouret, Carole Colin, et al.
Acta Neuropathologica Communications|November 21, 2013
Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytomaSandy Mercurio, Laetitia Padovani, Carole Colin, et al.
Cancer Cell International|July 3, 2025
The GD3 ganglioside promotes cell growth, plasticity and chemotherapy resistance of human glioblastoma cancer stem cellsVictoria Hein, Nathalie Baeza-Kallee, Raphaël Bergès, et al.
Neuro-Oncology|October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohortDomique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Pageof 7